2004-06-09-世界卫生组织-Report_of_the_4th_Meeting_of_the_Strategic_and_Technical_Advisory_Group_for_TB_21页_872kb

Summary of the Fourth Strategic and Technical Advisory Group for Tuberculosis (STAG-TB) Meeting (7-9 June 2004)

Core Content

The Fourth Strategic and Technical Advisory Group for Tuberculosis (STAG-TB) meeting was held at WHO Headquarters in Geneva from 7 to 9 June 2004. The meeting aimed to provide scientific and technical guidance to WHO on global tuberculosis (TB) control, evaluate progress on previous recommendations, and discuss strategic directions for future initiatives.

Main Objectives and Outcomes

The meeting had several key objectives, including:

1. Briefing on Global TB Situation: STAG-TB members were briefed on the global TB epidemiological and control situation, as well as WHO's activities and direction.
2. Follow-up on 2003 STAG Recommendations: STAG appreciated the thorough response from WHO and the regions and recommended the development of a report on global TB control highlights.
3. Review of Regional Work Programmes: Each regional office (AMRO, SEARO, EMRO, AFRO, WPRO, EURO) was evaluated on their progress and challenges in achieving 2005 targets.
4. Monitoring and Evaluation: STAG recommended the formation of a task force by WHO to improve the measurement and impact assessment of TB control.
5. Policy Development and Implementation: STAG emphasized the need for more explicit planning and transfer of evidence-based policies, and encouraged collaboration with professional societies and public institutions.
6. Treatment Guidelines: STAG endorsed revisions to the third edition of the Treatment of Tuberculosis: Guidelines for National Programmes, including the preference for 4HR and the need for daily administration of the 8th month regimen for Category I patients.
7. TB/HIV Strategy: STAG supported the integration of TB and HIV services, recommended strengthening of surveillance and evaluation, and encouraged collaboration between TB and HIV programs.
8. Laboratory Strengthening: STAG endorsed a framework for a strategic plan to strengthen laboratory capacity, including operational research on new technologies and better recognition of lab staff.
9. TB and Poverty: STAG recommended clarifying how guidance on TB and poverty can improve access to services and treatment outcomes for the poor.
10. Collaboration with TDR: STAG called for stronger institutional links between WHO's Stop TB Department (STB) and the Tuberculosis Drug Research (TDR) program.
11. Improving STAG Effectiveness: STAG suggested improvements in meeting preparation, prioritization, and location to enhance its effectiveness.

Key Recommendations

• Global TB Report: Develop a report on global TB control highlights to accompany the 2004 Executive Board resolution.
• DOTS Strategy Integration: Strengthen the integration of the DOTS strategy within health systems.
• Regional Reports: Regions should report on progress towards 2005 targets, with special attention to countries like India, Pakistan, and Vietnam.
• ISAC Program: ISAC should be led by countries, focus on capacity building, and be complementary to new funding mechanisms.
• Policy Transfer: Improve policy development, transfer, and implementation through collaboration with various stakeholders and the use of technology.
• Treatment Guidelines: Clarify the use of fixed-dose combinations (FDCs) and ensure daily administration of the 8th month regimen for Category I patients.
• TB/HIV Collaboration: Strengthen institutional links at both global and country levels, and enhance the role of NTPs in ARV delivery.
• Laboratory Strengthening: Develop a strategic plan for laboratory capacity, including performance indicators and technology transfer.
• TB and Poverty Network: Prepare guidelines and a network to address TB and poverty issues, with input from partners in health financing and social mobilization.
• Joint Research Agenda: STB and TDR should collaborate on a joint research agenda, including a 2005 scientific working group meeting.
• Enhanced Advocacy: Develop a comprehensive strategy for advocacy, communication, and social mobilization, with a focus on community-level literacy and global advocacy efforts.

Meeting Details

• Chairperson: Dr. Roberto Tapia-Conyer (Dr. Jaap Broekmans was unable to attend).
• Vice-Chair: Dr. P.R. Narayanan.
• Rapporteur: Ms. Diana Weil.
• Meeting Location: Geneva, Switzerland.
• Duration: 3 days.
• Participants: 18 STAG-TB members, 5 co-opted members, and various observers from international organizations and countries.

Membership and Contact Information

The STAG-TB members include experts from various disciplines and countries, with detailed contact information provided for each. Co-opted members and observers also attended, representing key stakeholders such as the Global Fund and the Gates Foundation.

Conclusion

The meeting emphasized the importance of a coordinated, evidence-based, and inclusive approach to TB control, focusing on policy development, implementation, and the integration of TB with other health issues such as HIV and poverty. It also highlighted the need for improved collaboration, capacity building, and the strengthening of laboratory and health workforce systems.